"A New Way to Fight Diabetes" Newsweek. November 15, 1993. Dohm, G. L.; Elton, C. W.; Raju, M. S.; Mooney, N. D.; DiMarchi, R.; Pories, W. J.; Flickinger,
Aranda P. "Insulin in bovine colostrum and milk: evolution throughout lactation and binding to caseins." J Dairy Sci. 1991 Dec;74(12):4320-5..
Binz, K. et al. Repopulation of The Atrophied Thymus in Diabetic Rats by Insulin-like Grown Factor I. Proc. Natl. Acad. Sci. USA. 87(10):3690-3694. May 1990.
Chen, W, et al. Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology 145(2):627-638 (2004). IGF-1 regulates beta cell growth, survival and metabolism in the pancreas and protects them against development of type 1 diabetes. Using IGF-1 combined with IGF-binding protein (IGF-bp) significantly increases the efficacy of IGF-1 treatment by extending its half-life in the body.
Dohm, Elton, et al. IgF-1 stimulated glucose transport. Diabetes, Sept. 30, 1990, pp. 1028-32.
Dohm. G.; et al. "IGF-1 Stimulated Glucose Transport in Human Skeletal Muscle and IGF-I Resistance in Obesity and NIDDM," Diabetes. 39(9):1028-1032, 1990.
McDevitt, H. "Characteristics of Autoimmunity in Type 1 Diabetes and Type 1.5 Overlap With Type 2 Diabetes" Section I: Aspects of PathophysiologyDiabetes 54:S4-S10, 2005. Department of Medicine, and Microbiology and Immunology, Stanford University School of Medicine, Stanford, California.
Pennisi. "Immune Therapy Stems Diabetes Progress" Science News. 145:37, January 15, 1995.
Tuomi, T. "Type 1 and Type 2 Diabetes, What Do They Have in Common?" Section I: Aspects of Pathophysiology Diabetes 54:S40-S45, 2005. From the Department of Internal Medicine/Diabetology, Helsinki University Central Hospital; the Institute for Diabetes Genetics, Folkhalsan Research Center, Helsinki, Finland; and the Research Program for Molecular Medicine, University of Helsinki, Helsinki, Finland.
Stone, T. "Components in Colostrum Balance Blood Sugar Levels and Reduce Insulin Requirements" Colostrum Can Stabilize Blood Sugar, 1993
Thivolet, C. Use of IGF-1 or analogues thereof in the prevention of diabetes. US Patent #6,342,227 (2002). IGF-1 or an analogue can delay the clinical onset of diabetes when administered at the first sign of the disease. Additionally, IGF-1 or analogue given to patients at high risk for developing the disease significantly reduces the likelihood of developing diabetes.
Vaarla, O. The gut immune system and type 1 diabetes. Annals of the New York Academy of Science 958:39-46 (2002). There is increasing evidence that the gut immune system is important in the development of type 1 (autoimmune) diabetes. One of the causes of type diabetes in children may be too early introduction of cow’s milk to the diet in infants, which causes an autoimmune response to insulin.